Likewise, inactivation of wild-type KRAS was expected to increase tumor number and/or growth in the KRAS G12C and KRAS G12D contexts, as wild-type KRAS suppresses oncogenic KRAS33. The gene discussed is KRAS; the disease is neoplasm.